Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
The global market for Gene Fragment Synthesis was estimated to be worth US$ 226 million in 2023 and is forecast to a readjusted size of US$ 392.1 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030
North American market for Gene Fragment Synthesis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Fragment Synthesis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Gene Fragment Synthesis was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Gene Fragment Synthesis include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, Twist Bioscience, Synbio Technologies, Bio Basic and BiOligo Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Fragment Synthesis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Fragment Synthesis by region & country, by Type, and by Application.
The Gene Fragment Synthesis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment Synthesis.
麻豆原创 Segmentation
By Company
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Segment by Type:
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Fragment Synthesis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Gene Fragment Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Gene Fragment Synthesis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Gene Fragment Synthesis Product Introduction
1.2 Global Gene Fragment Synthesis 麻豆原创 Size Forecast
1.3 Gene Fragment Synthesis 麻豆原创 Trends & Drivers
1.3.1 Gene Fragment Synthesis Industry Trends
1.3.2 Gene Fragment Synthesis 麻豆原创 Drivers & Opportunity
1.3.3 Gene Fragment Synthesis 麻豆原创 Challenges
1.3.4 Gene Fragment Synthesis 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Fragment Synthesis Players Revenue Ranking (2023)
2.2 Global Gene Fragment Synthesis Revenue by Company (2019-2024)
2.3 Key Companies Gene Fragment Synthesis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Fragment Synthesis Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Fragment Synthesis
2.6 Gene Fragment Synthesis 麻豆原创 Competitive Analysis
2.6.1 Gene Fragment Synthesis 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Fragment Synthesis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Fragment Synthesis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0-999 bp
3.1.2 1000-1999 bp
3.1.3 2000-3999 bp
3.1.4 4000+ bp
3.2 Global Gene Fragment Synthesis Sales Value by Type
3.2.1 Global Gene Fragment Synthesis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Fragment Synthesis Sales Value, by Type (2019-2030)
3.2.3 Global Gene Fragment Synthesis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 CRISPR-based Genome Editing
4.1.2 Antibody Engineering
4.1.3 Cloning Process
4.1.4 Others
4.2 Global Gene Fragment Synthesis Sales Value by Application
4.2.1 Global Gene Fragment Synthesis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Fragment Synthesis Sales Value, by Application (2019-2030)
4.2.3 Global Gene Fragment Synthesis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Fragment Synthesis Sales Value by Region
5.1.1 Global Gene Fragment Synthesis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Fragment Synthesis Sales Value by Region (2019-2024)
5.1.3 Global Gene Fragment Synthesis Sales Value by Region (2025-2030)
5.1.4 Global Gene Fragment Synthesis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Fragment Synthesis Sales Value, 2019-2030
5.2.2 North America Gene Fragment Synthesis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Fragment Synthesis Sales Value, 2019-2030
5.3.2 Europe Gene Fragment Synthesis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Fragment Synthesis Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Fragment Synthesis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Fragment Synthesis Sales Value, 2019-2030
5.5.2 South America Gene Fragment Synthesis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Fragment Synthesis Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Fragment Synthesis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Fragment Synthesis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Fragment Synthesis Sales Value
6.3 United States
6.3.1 United States Gene Fragment Synthesis Sales Value, 2019-2030
6.3.2 United States Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Fragment Synthesis Sales Value, 2019-2030
6.4.2 Europe Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Fragment Synthesis Sales Value, 2019-2030
6.5.2 China Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Fragment Synthesis Sales Value, 2019-2030
6.6.2 Japan Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Fragment Synthesis Sales Value, 2019-2030
6.7.2 South Korea Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Fragment Synthesis Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Fragment Synthesis Sales Value, 2019-2030
6.9.2 India Gene Fragment Synthesis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Fragment Synthesis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Integrated DNA Technologies
7.1.1 Integrated DNA Technologies Profile
7.1.2 Integrated DNA Technologies Main Business
7.1.3 Integrated DNA Technologies Gene Fragment Synthesis Products, Services and Solutions
7.1.4 Integrated DNA Technologies Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.1.5 Integrated DNA Technologies Recent Developments
7.2 Thermo Scientific
7.2.1 Thermo Scientific Profile
7.2.2 Thermo Scientific Main Business
7.2.3 Thermo Scientific Gene Fragment Synthesis Products, Services and Solutions
7.2.4 Thermo Scientific Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Scientific Recent Developments
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Profile
7.3.2 Eurofins Scientific Main Business
7.3.3 Eurofins Scientific Gene Fragment Synthesis Products, Services and Solutions
7.3.4 Eurofins Scientific Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.3.5 GenScript Biotech Recent Developments
7.4 GenScript Biotech
7.4.1 GenScript Biotech Profile
7.4.2 GenScript Biotech Main Business
7.4.3 GenScript Biotech Gene Fragment Synthesis Products, Services and Solutions
7.4.4 GenScript Biotech Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.4.5 GenScript Biotech Recent Developments
7.5 Azenta Life Sciences
7.5.1 Azenta Life Sciences Profile
7.5.2 Azenta Life Sciences Main Business
7.5.3 Azenta Life Sciences Gene Fragment Synthesis Products, Services and Solutions
7.5.4 Azenta Life Sciences Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.5.5 Azenta Life Sciences Recent Developments
7.6 Twist Bioscience
7.6.1 Twist Bioscience Profile
7.6.2 Twist Bioscience Main Business
7.6.3 Twist Bioscience Gene Fragment Synthesis Products, Services and Solutions
7.6.4 Twist Bioscience Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.6.5 Twist Bioscience Recent Developments
7.7 Synbio Technologies
7.7.1 Synbio Technologies Profile
7.7.2 Synbio Technologies Main Business
7.7.3 Synbio Technologies Gene Fragment Synthesis Products, Services and Solutions
7.7.4 Synbio Technologies Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.7.5 Synbio Technologies Recent Developments
7.8 Bio Basic
7.8.1 Bio Basic Profile
7.8.2 Bio Basic Main Business
7.8.3 Bio Basic Gene Fragment Synthesis Products, Services and Solutions
7.8.4 Bio Basic Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.8.5 Bio Basic Recent Developments
7.9 BiOligo Biotechnology
7.9.1 BiOligo Biotechnology Profile
7.9.2 BiOligo Biotechnology Main Business
7.9.3 BiOligo Biotechnology Gene Fragment Synthesis Products, Services and Solutions
7.9.4 BiOligo Biotechnology Gene Fragment Synthesis Revenue (US$ Million) & (2019-2024)
7.9.5 BiOligo Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Gene Fragment Synthesis Industrial Chain
8.2 Gene Fragment Synthesis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Fragment Synthesis Sales Model
8.5.2 Sales Channel
8.5.3 Gene Fragment Synthesis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
听
听
*If Applicable.
